A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Clinical trial NCT01220271 · COMPLETED
Trial details
- NCT number
- NCT01220271
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2015-08-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.